Journal article icon

Journal article

Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.

Abstract:

Overexpression of the human epidermal growth factor receptor (HER) 2 has been linked to the development and maintenance of malignant phenotypes in breast tumors. In addition, the growth and dissemination of human cancers are regulated in part by the autocrine motility factor (AMF)/phosphoglucose isomerase shown to be up-regulated by heregulin (HRG) in breast cancer cells. This study was undertaken to explore the effect of anti-HER2 monoclonal antibody 4D5 [Herceptin (HCT)] on AMF expression a...

Expand abstract
Publication status:
Published

Actions


Authors


Talukder, AH More by this author
Bagheri-Yarmand, R More by this author
Williams, RR More by this author
Ragoussis, J More by this author
Expand authors...
Journal:
Clinical cancer research : an official journal of the American Association for Cancer Research
Volume:
8
Issue:
10
Pages:
3285-3289
Publication date:
2002-10-05
ISSN:
1078-0432
URN:
uuid:cc93ce00-3e80-4fa9-ad9c-c8b8c9040f3e
Source identifiers:
71804
Local pid:
pubs:71804

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP